Neville Rodie & Shaw Inc Abb Vie Inc. Transaction History
Neville Rodie & Shaw Inc
- $1.36 Billion
- Q3 2024
A detailed history of Neville Rodie & Shaw Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 100,915 shares of ABBV stock, worth $18.5 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
100,915
Previous 95,743
5.4%
Holding current value
$18.5 Million
Previous $16.4 Million
21.36%
% of portfolio
1.47%
Previous 1.25%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
3,849Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$31.4 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$25 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.54 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.09 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $324B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...